Article
Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.
The Journal of infectious diseases - 15 Oct 2016
Whitmer Shannon L M, Albariño César, Shepard Samuel S, Dudas Gytis, Sheth Mili, Brown Shelley C, Cannon Deborah, Erickson Bobbie R, Gibbons Aridth, Schuh Amy, Sealy Tara, Ervin Elizabeth, Frace Mike, Uyeki Timothy M, Nichol Stuart T, Ströher Ute
Abstract excerpt
BACKGROUND: Several patients with Ebola virus disease (EVD) managed in the United States have received ZMapp monoclonal antibodies, TKM-Ebola small interfering RNA, brincidofovir, and/or convalescent plasma as investigational therapeutics. METHODS: To investigate whether treatment selected for Ebola virus (EBOV) mutations conferring resistance, viral sequencing was performed on RNA extracted from clinical blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
